Menu Close

Articles on AstraZeneca

Displaying all articles

mRNA technologies for vaccine production is gaining more prominence Lulama Zenzile/Die Burger/Gallo Images via Getty Images

Messenger RNA: how it works in nature and in making vaccines

Thanks to the collaborative efforts of governments, funding agencies, academia, biotech and pharmaceutical companies, large-scale manufacturing of mRNA drug products is becoming a reality.
The first Pfizer-BioNTech COVID-19 vaccine dose in Canada sits ready for use at The Michener Institute in Toronto in mid-December 2020, less than a year from when the World Health Organization declared COVID-19 a pandemic. THE CANADIAN PRESS/Frank Gunn

Big Pharma’s COVID-19 reputation boost may not last — here’s why

If Big Pharma wants to achieve the ultimate image makeover, it must capitalize on the current public good will about its COVID-19 vaccines by prioritizing socially responsible practices.
Photo by Sharon Seretlo/Gallo Images via Getty Images

South Africa’s vaccine quagmire, and what needs to be done now

South Africa has clearly suffered the consequences of poor strategic decisions to this point. It doesn’t need to continue along these lines.

Top contributors

More